Compelling evidence demonstrated both protumoral and antitumoral effects of CCL2, while CCL2 exhibits tumor‐promoting activities by the recruitment of TAMs and myeloid‐derived suppressor cells (MDSCs), as well as the stimulation of tumor cell invasiveness; the antitumoral potential of CCL2 majorly contributed due to its ability of immune stimulation and inflammation against the tumor [36]. The gene discussed is CCL2; the disease is neoplasm.